Latest Breaking News On - Sanzyme biologics - Page 2 : comparemela.com

Hyderabad (Telangana) [India], November 29 (ANI/PRNewswire): Latest study shows Sanzyme Biologics's Bacillus coagulans SNZ 1969 (Weizmannia coagulans SNZ 1969), a natural spore forming probiotic strain over five decades of use and more than 30 human studies across age groups found to be effective in managing IBS symptoms. This study is unique as it covers both the IBS-Diarrhea and IBS-Constipation groups with larger number of subjects. Irritable bowel syndrome (IBS) is one of the most common disorders of gut-brain interaction, estimated to affect around 11 per cent people globally. The outcome of this study will be significant to supplement manufacturers as it can help design products to address consumer need for managing IBS symptoms with a scientifically studied probiotic strain. Several factors, such as the increasing fear of antibiotic resistance, the increasing demand of consumers for natural substitutes for drugs, and the emergence of scientific and clinical evidence showing

Sanzyme biologicsHyderabad telangana indiaOvember 29 ani prnewswire latest study shows sanzyme biologics 39s bacillus coagulans snz 1969 weizmanniaA natural spore forming probiotic strain over five decades of use and more than 30 human studies across age groups found to be effective in managing ibs symptoms this study is unique as it covers both the diarrhea constipation with larger number subjects irritable bowel syndrome one most common disorders gut brain interactionStimated to affect around 11 per cent people globally the outcome of this study will be significant supplement manufacturers as it can help design products address consumer need for managing ibs symptoms witha scientifically studied probiotic strain several factorsUch as the increasing fear of antibiotic resistanceHe increasing demand of consumers for natural substitutes drugsNd the emergence of scientific and clinical evidence showing efficacy probioticsAve contributed to many health professionals considering probiotics as an alternative drug remedies ina randomizedDouble blindPlacebo controlled studyRobiotic potential of snz 1969 has been studied in subjects with constipation predominant irritable bowel syndrome ibsc and diarrhea ibsd significant reduction gsrs ibs score was seen both the treatment group compared to placebop lt 0 0001 well tolerated showed alleviation associated clinical symptoms placebo improved quality life patients this study conducted at apollo hospitalsNdia and published in the international journal of basic amp clinical pharmacology https www ijbcp com index php article view 5120 same strain has been studied earlier for gastrointestinal discomfortNtestinal motility and intermittent constipation among healthy subjects gi discomfort study showed an improvement in total soda scoresNcluding specific symptoms such as burping belchingPassing gas